Immer 2007.
| Study characteristics | ||
| Methods | Randomised substudy – cohort of larger patients Run‐in period: not specified. Accepted for publication May 29, 2007 Number of centres and location: University Hospital, Berne, Switzerland |
|
| Participants | A total of 1053 patients were assessed in this study; 60 participants were randomised to MiECC or CCPB circuit. Inclusion criteria: patients undergoing CABG Exclusion criteria: re‐do CABG and combined CABG operations (with valve surgery, aortic surgery, or both) |
|
| Interventions | Intervention: MiECC Control: CCPB |
|
| Outcomes | cTnI, CK‐MB, IL‐6, SC5b‐9, human lactoferrin (HL) | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | No details given |
| Allocation concealment (selection bias) | Unclear risk | No details given |
| Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No details given |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No details given |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | All data included in analysis |
| Selective reporting (reporting bias) | Low risk | No reporting bias apparent |
| Other bias | Unclear risk | No details given |